Distinct 3D Architecture and Dynamics of the Human HtrA2(Omi) Protease and Its Mutated Variants

被引:10
|
作者
Gieldon, Artur [1 ]
Zurawa-Janicka, Dorota [2 ]
Jarzab, Miroslaw [2 ]
Wenta, Tomasz [2 ]
Golik, Przemyslaw [3 ]
Dubin, Grzegorz [3 ,4 ]
Lipinska, Barbara [2 ]
Ciarkowski, Jerzy [1 ]
机构
[1] Univ Gdansk, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland
[2] Univ Gdansk, Dept Biochem, Fac Biol, PL-80308 Gdansk, Poland
[3] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland
[4] Malopolska Ctr Biotechnol, Ul Gronostajowa 7A, PL-30387 Krakow, Poland
来源
PLOS ONE | 2016年 / 11卷 / 08期
关键词
MITOCHONDRIAL QUALITY-CONTROL; SERINE-PROTEASE; CRYSTAL-STRUCTURE; HTRA-FAMILY; PARKINSONS-DISEASE; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; STRESS SENSOR; ACTIVATION; DOMAIN;
D O I
10.1371/journal.pone.0161526
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HtrA2(Omi) protease controls protein quality in mitochondria and plays a major role in apoptosis. Its HtrA2(S306A) mutant (with the catalytic serine routinely disabled for an X-ray study to avoid self-degradation) is a homotrimer whose subunits contain the serine protease domain (PD) and the regulatory PDZ domain. In the inactive state, a tight inter-domain interface limits penetration of both PDZ-activating ligands and PD substrates into their respective target sites. We successfully crystalized HtrA2(V226K/S306A), whose active counterpart HtrA2(V226K) has had higher proteolytic activity, suggesting higher propensity to opening the PD-PDZ interface than that of the wild type HtrA2. Yet, the crystal structure revealed the HtrA2(V226K/S306A) architecture typical of the inactive protein. To get a consistent interpretation of crystallographic data in the light of kinetic results, we employed molecular dynamics (MD). V325D inactivating mutant was used as a reference. Our simulations demonstrated that upon binding of a specific peptide ligand NH2-GWTMFWV-COOH, the PDZ domains open more dynamically in the wild type protease compared to the V226K mutant, whereas the movement is not observed in the V325D mutant. The movement relies on a PDZ vs. PD rotation which opens the PD-PDZ interface in a lid-like (budding flower-like in trimer) fashion. The noncovalent hinges A and B are provided by two clusters of interfacing residues, harboring V325D and V226K in the C- and N-terminal PD barrels, respectively. The opening of the subunit interfaces progresses in a sequential manner during the 50 ns MD simulation. In the systems without the ligand only minor PDZ shifts relative to PD are observed, but the interface does not open. Further activation-associated events, e.g. PDZ-L3 positional swap seen in any active HtrA protein (vs. HtrA2), were not observed. In summary, this study provides hints on the mechanism of activation of wtHtrA2, the dynamics of the inactive HtrA2(V325D), but does not allow to explain an increased activity of HtrA2(V226K).
引用
收藏
页数:19
相关论文
共 50 条
  • [11] The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi
    K Klupsch
    J Downward
    Cell Death & Differentiation, 2006, 13 : 2157 - 2159
  • [12] Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils
    Blink, E
    Maianski, NA
    Alnemri, ES
    Zervos, AS
    Roos, D
    Kuijpers, TW
    CELL DEATH AND DIFFERENTIATION, 2004, 11 (08): : 937 - 939
  • [13] A specific inhibitor of Omi/HtrA2 protease prevents production of inflammatory cytokines in UVB-irradiated human keratinocytes
    Yahagi, S.
    Okano, Y.
    Zervos, A.
    Masaki, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 135 - 135
  • [14] Stress Conditions Increase Vimentin Cleavage by Omi/HtrA2 Protease in Human Primary Neurons and Differentiated Neuroblastoma Cells
    Bérangère Lucotte
    Mehdi Tajhizi
    Dareen Alkhatib
    Eva-Britt Samuelsson
    Birgitta Wiehager
    Sophia Schedin-Weiss
    Erik Sundström
    Bengt Winblad
    Lars.O Tjernberg
    Homira Behbahani
    Molecular Neurobiology, 2015, 52 : 1077 - 1092
  • [15] The serine protease OMI/HtrA2 interacts with PED (phosphoprotein enriched in diabetes) and controls its anti-apoptotic function
    Trencia, A
    Fiory, F
    Alessan-Dramaitan, M
    Cassese, A
    Autuori, E
    Miele, C
    Formisano, P
    Beguinot, F
    DIABETES, 2003, 52 : A423 - A423
  • [16] THE ROLE OF OMI/HTRA2 PROTEASE IN NEONATAL POSTASPHYXIAL SERUM-INDUCED APOPTOSIS IN HUMAN KIDNEY PROXIMAL TUBULE CELLS
    Zhang, Yong
    Dong, Wen-Bin
    Li, Qing-Ping
    Deng, Chun-Liang
    Xiong, Tao
    Lei, Xiao-Ping
    Guo, Lin
    ARCHIVES OF BIOLOGICAL SCIENCES, 2012, 64 (02) : 435 - 444
  • [17] THE ROLE OF OMI/HTRA2 PROTEASE IN NEONATAL POSTASPHYXIAL SERUM-INDUCED APOPTOSIS IN HUMAN KIDNEY PROXIMAL TUBULE CELLS
    Zhang, Yong
    Dong, Wen-Bin
    Li, Qing-Ping
    Deng, Chun-Liang
    Xiong, Tao
    Lei, Xiao-Ping
    Guo, Lin
    ARCHIVES OF BIOLOGICAL SCIENCES, 2012, 64 (04) : 1505 - 1514
  • [18] Inactivation of Omi/HtrA2 protease leads to the deregulation of mitochondrial Mulan E3 ubiquitin ligase and increased mitophagy
    Cilenti, Lucia
    Ambivero, Camilla T.
    Ward, Nathan
    Alnemri, Emad S.
    Germain, Doris
    Zervos, Antonis S.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2014, 1843 (07): : 1295 - 1307
  • [19] Changes in expression of human serine protease HtrA1, HtrA2 and HtrA3 genes in benign and malignant thyroid tumors
    Zurawa-Janicka, Dorota
    Kobiela, Jaroslaw
    Galczynska, Natalia
    Stefaniak, Tomasz
    Lipinska, Barbara
    Lachinski, Andrzej
    Skorko-Glonek, Joanna
    Narkiewicz, Joanna
    Proczko-Markuszewska, Monika
    Sledzinski, Zbigniew
    ONCOLOGY REPORTS, 2012, 28 (05) : 1838 - 1844
  • [20] HtrA2/Omi protease in epithelial ovarian carcinoma: clinical significance and antineoplastic efficacy of its overexpression on subcutaneous transplanted tumor in nude mice model
    Wang, Lei
    Diao, Yu-Chao
    Jiao, Jin-Wen
    Wang, Chang
    Yu, Jie
    Li, Bo
    Dai, Shu-Zhen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (03): : 3161 - 3169